Scientists devise method for faster detection of rare leukemia

10/6/2008 | FDAnews · Yahoo!

U.S. researchers have developed a technique to detect juvenile myelomonocytic leukemia -- a rare type of the disease -- within a few hours rather than weeks. The method, which is based on flow cytometry, uses fluorescent-tagged antibodies to identify and organize cells that have the STAT5 protein in patients with the disease. The approach may prove useful in evaluating the efficacy of potential drug therapies against JMML and other conditions, researchers said.

View Full Article in:

FDAnews · Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ